Quantitative testing a set of biomarkers:

100µL whole blood, 12 minutes

Celeras Dx’ patient monitoring delivers speedy status reports on biomarkers which are associated with clinical decisions to be made during treatment of serious infection - especially sepsis. The tests have been conceived for the periodic testing of patients in such a manner that the minimum use of samples is involved and a simple and rapid analysis is available. The aim is to deliver a “picture” of the inflammation and organ status which is as complete as possible and which quickly indicates any deterioration in the condition of the patient.


The sample is pipetted into the hybcell (=cartridge). The sample dissolves a reaction mix lyophilised within the cartridge. The hybcells are transferred to the hyborg – the fully automatic device. The measured values are interpreted by the software and presented within the measurement range as quantitative results in a tabulated report.


xA panel (Research Use Only):

  • CRP - acute-phase protein-marker for inflammation.
  • Cystatin C - protease inhibitor indicating kidney failure.
  • Myoglobin - elevated levels indicate damages of heart muscle.
  • NGAL - elevated levels indicate damages of kidney.
  • PCT - is elevated during bacterial infections.
  • Plasminogen and D-Dimer - are biomarkers for the status of coagulation.
  • Serumamyloid A (SAA) - is an acute-phase protein-marker elevated during bacterial- and viral infections.
  • Tachykinin (Substance P) - is a neurotransmitter and a marker for a progressed stage of sepsis.
  • One sample, many answers
  • Easy handling
  • Fast results in 12 minutes
  • Low sample volume (100µL whole blood)

hybcell PM Blood xA

Multiplexed Immuno-test of 9 markers

12 x hybcell

Available Liturature

Value of single and combined inflammatory and kidney-dependent parameters for prediction of prognosis in septic shock
2015_10_25 LMUMUNICH MultiplexBiomarkers
Adobe Acrobat Document 924.9 KB